— Know what they know.
Not Investment Advice

STEK OTC

Stemtech Corporation
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -88.9% 1Y: -99.2% 3Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $216929 mcap · 1.94B float · 1.44% daily turnover · Short 95% of daily vol

Balance Sheet Trends

Total Assets
$4M +2.7% ▲
5Y CAGR: -8.3%
Total Liabilities
$9M +39.4% ▲
5Y CAGR: +22.3%
Shareholders Equity
-$4M -119.9% ▼
Cash & Investments
$255K +123.6% ▲
5Y CAGR: +0.4%
Total Debt
$4M +3.2% ▲
5Y CAGR: +35.5%
Net Debt
$4M -0.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$133K$828K$132K$114K$255K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$133K$828K$132K$114K$255K
Net Receivables$26K$11K$35K$61K$270K
Inventory$199K$436K$158K$48K$197K
Other Current Assets$0$325K$287K$177K$199K
Total Current Assets$573K$2M$612K$401K$922K
Property, Plant & Equip.$126K$207K$170K$81K$0
Goodwill & Intangibles$4M$4M$3M$3M$3M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$27K$39K$23K$24K$17K
Total Non-Current Assets$4M$4M$4M$3M$3M
Total Assets$5M$6M$4M$4M$4M
— Liabilities —
Accounts Payable$3M$4M$3M$3M$5M
Short-Term Debt$795K$1M$1M$4M$4M
Deferred Revenue-$870K$0$39K$56K$1K
Other Current Liabilities$0$4M$3M$0$674K
Total Current Liabilities$4M$9M$7M$6M$9M
Long-Term Debt$18K$219K$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$18K$339K$23K$0$0
Total Liabilities$4M$10M$7M$6M$9M
— Equity —
Common Stock$34K$45K$53K$105K$136K
Retained Earnings-$6M-$13M-$22M-$27M-$31M
Accumulated OCI-$411K-$430K-$248K$191K-$146K
Total Stockholders Equity$2M-$3M-$2M-$2M-$4M
Total Liabilities & Equity$5M$6M$4M$4M$4M
— Key Metrics —
Total Debt$889K$1M$1M$4M$4M
Net Debt$756K$622K$1M$4M$4M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms